Gastric Cancer

CLINICAL_TRIALS trial_result · 2023-07-06

Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer [Phase 2]

A Phase 2 clinical trial exploring conversion therapy with sintilimab plus apatinib and chemotherapy in stage IV gastric cancer.

CLINICAL_TRIALS trial_result · 2023-07-05

Clinical Trial Update: Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab [Phase 2]

Phase 2 clinical trial evaluating disitamab vedotin in combination with sintilimab for gastric cancer.

CLINICAL_TRIALS trial_result · 2023-06-27

Clinical Trial Update: Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09) [Phase 2]

Phase 2 trial update evaluating cryoablation with tislelizumab and lenvatinib in previously treated gastric cancer with liver metastases.

CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer [Phase 2]

Phase 2 trial evaluating tislelizumab combined with chemotherapy for cross-line treatment in first-line resistant advanced gastric cancer.

CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach [Phase 2]

Phase 2 clinical trial update evaluating combination chemotherapy after surgery in patients with esophageal or gastric cancer.

CLINICAL_TRIALS trial_result · 2023-06-09

Clinical Trial Update: A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer [Phase 2]

A Phase 2 clinical trial in advanced gastric cancer evaluating combination treatments has completed with results posted.

CLINICAL_TRIALS trial_result · 2023-06-01

Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]

Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…

CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer [Phase 2]

Phase 2 trial update evaluating surgical conversion with Candonilimab (AK104) plus Paclitaxel, S-1, and Apatinib for unresectable advanced g…

CLINICAL_TRIALS trial_result · 2023-05-06

Clinical Trial Update: Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery [Phase 2]

Phase 2 clinical trial evaluating tirelizumab plus chemotherapy versus chemotherapy alone in patients with lymph node–positive gastric cance…

CLINICAL_TRIALS trial_result · 2023-04-26

Clinical Trial Update: Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy [Phase 3]

Phase 3 trial evaluating early palliative care in patients with metastatic upper gastrointestinal cancers treated with first-line chemothera…

CLINICAL_TRIALS trial_result · 2023-04-25

Clinical Trial Update: Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC [Phase 2]

Phase 2 trial investigating perioperative chemotherapy combined with tislelizumab and trastuzumab for stomach cancer/early gastric cancer.

CLINICAL_TRIALS trial_result · 2023-04-21

Clinical Trial Update: Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinoma [Phase 2]

A Phase 2 clinical trial investigating camrelizumab (SHR-1210) with apatinib-based therapies for AFP-producing gastric cancer or gastroesoph…

CLINICAL_TRIALS trial_result · 2023-04-18

Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]

Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…

CLINICAL_TRIALS trial_result · 2023-04-13

Clinical Trial Update: Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer [Phase 2]

Phase 2 clinical trial evaluating nab-paclitaxel with oxaliplatin and S-1 as perioperative treatment for advanced gastric cancer.

CLINICAL_TRIALS trial_result · 2023-04-12

Clinical Trial Update: Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study [Phase 2]

A Phase 2 single-arm prospective study evaluating Fruquintinib with PD-1 inhibitors as first-line maintenance therapy for advanced gastric c…

CLINICAL_TRIALS trial_result · 2023-03-30

Clinical Trial Update: Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063) [Phase 3]

Phase 3 trial comparing pembrolizumab to paclitaxel in Asian patients with advanced gastric or gastroesophageal junction adenocarcinoma afte…

CLINICAL_TRIALS trial_result · 2023-03-23

Clinical Trial Update: IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 1, Phase 2]

Phase 1/2 trial update evaluating IRX-2, cyclophosphamide, and pembrolizumab in recurrent or metastatic gastric or gastroesophageal junction…

CLINICAL_TRIALS trial_result · 2023-03-23

Clinical Trial Update: Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis [Phase 2]

Phase 2 clinical trial update on intraperitoneal chemotherapy for gastric cancer with peritoneal carcinomatosis.

CLINICAL_TRIALS trial_result · 2023-03-15

Clinical Trial Update: TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]

Phase 2 trial evaluating TAS-102 in combination with ramucirumab for advanced, refractory gastric or gastroesophageal junction adenocarcinom…

CLINICAL_TRIALS trial_result · 2023-03-15

Clinical Trial Update: A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer [Phase 2]

Phase 2 trial evaluating serplulimab with docetaxel + S-1 vs docetaxel + S-1 as adjuvant therapy in stage IIIc gastric cancer; status curren…

CLINICAL_TRIALS trial_result · 2023-03-13

Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors [Phase 1, Phase 2]

Phase 1/2 trial evaluating NKTR-214 in combination with nivolumab and other anti-cancer therapies in select advanced solid tumors completed …

CLINICAL_TRIALS trial_result · 2023-03-01

Clinical Trial Update: Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer [Phase 3]

Phase 3 trial evaluating sintilimab plus XELOX versus placebo plus XELOX as first-line treatment for gastric cancer; study completed.

CLINICAL_TRIALS trial_result · 2023-03-01

Clinical Trial Update: CKD-702 Plus Irinotecan in Gastric Cancer [Phase 2]

Phase 2 clinical trial update for CKD-702 in combination with irinotecan in gastric cancer; current status is unknown.

CLINICAL_TRIALS trial_result · 2023-02-09

Clinical Trial Update: Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer [Phase 2]

Phase II trial evaluating pembrolizumab with trastuzumab and chemotherapy in advanced HER2-positive esophagogastric cancer has completed and…

CLINICAL_TRIALS trial_result · 2023-02-09

Clinical Trial Update: Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer [Phase 2]

Phase 2 trial update evaluating disitamab vedotin with sintilimab as first-line treatment in elderly patients with gastric cancer.

Top drugs studied for this disease